BlossomHill Therapeutics, Inc. (NASDAQ:BLSM) Financings

BlossomHill Therapeutics, Inc.

Financings

RaiseDate
Public offering of common stock
Closed: US$168.3M raised · US$16 a share · J.P. Morgan +4
Dealers: J.P. Morgan (lead), Leerink Partners (lead), Guggenheim Securities (lead), LifeSci Capital (co-lead), H.C. Wainwright & Co. (co-lead)
Sep 18, 2026

Read by 6ix AI from the company's releases